Literature DB >> 929350

Treatment of secondary syphilis: an evaluation of 204 patients.

N J Fiumara.   

Abstract

Our recommended treatment schedule for secondary syphilis is intramuscular benzathine penicillin G, 2.4 million units weekly for two consecutive weeks. If the patient is allergic to penicillin, we recommend that 2 gm of oral tetracycline be given each day for 12 days. Two hundred and four patients with secondary syphilis were treated with these schedules; 165 were given benzathine penicillin G and 39 received tetracycline. All of the patients were cured clinically and all achieved seronegativity within 24 months. There was a direct correlation between the duration of the rash and the secondary lesions that the patients exhibited. Patients who presented early in the course of illness tended to have macular and maculopapular lesions, whereas those who appeared later were more likely to have papular of pustular lesions. The serologic response to treatment was correlated with the duration of the rash and the appearance of the secondary lesions. Patients whose rash was of short duration and those with macular and maculopapular lesions became seronegative sooner than those patients whose rash was of longer duration and who had papular or pustular lesions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929350     DOI: 10.1097/00007435-197707000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Treating Syphilis: Examining therapeutic approaches to this STD.

Authors:  W D Colby
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

3.  Primary and secondary syphilis, 20 years' experience. 3: Diagnosis, treatment, and follow up.

Authors:  J Anderson; A Mindel; S J Tovey; P Williams
Journal:  Genitourin Med       Date:  1989-08

4.  Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis.

Authors:  Arlene C Seña; Mark Wolff; Frieda Behets; David H Martin; Peter Leone; Carol Langley; Linda McNeil; Edward W Hook
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

5.  The role of treponemal tests in therapeutic decision making.

Authors:  G Hart
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

6.  Treatment failure with penicillin in early syphilis.

Authors:  A J Giles; A G Lawrence
Journal:  Br J Vener Dis       Date:  1979-02

7.  Secondary syphilis of the tonsil.

Authors:  T Shimizu; J Shinogi; Y Majima; Y Sakakura
Journal:  Arch Otorhinolaryngol       Date:  1989

8.  Secondary syphilis: uncommon manifestations of a common disease.

Authors:  S J McPhee
Journal:  West J Med       Date:  1984-01

9.  Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms.

Authors:  Khalil G Ghanem; Richard D Moore; Anne M Rompalo; Emily J Erbelding; Jonathan M Zenilman; Kelly A Gebo
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

10.  Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.

Authors:  Khalil G Ghanem; Richard D Moore; Anne M Rompalo; Emily J Erbelding; Jonathan M Zenilman; Kelly A Gebo
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.